The structural biology of growth factor receptor activation

Biophysical Chemistry

Volumn 100, Issue 1-3, 2002, Pages 545-553

  Harmer, Nicholas J ^a   Chirgadze, Dima ^a   Kim, Kyung Hyun ^a   Pellegrini, Luca ^a   Blundell, Tom L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Growth factor; Multiprotein complexes; Receptor; Structural biology

Indexed keywords

DIMER; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HEPARAN SULFATE; NERVE GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN;

ALPHA CHAIN; ARTICLE; BETA CHAIN; HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; RECEPTOR BINDING;

ANIMALS; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HEPATOCYTE GROWTH FACTOR; HUMANS; INSULIN; NERVE GROWTH FACTOR; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, INSULIN; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, SOMATOMEDIN; SOMATOMEDINS;

EID: 0037438629     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-4622(02)00305-8     Document Type: Article

References (39)

1. Wiess A., Schlessinger J. Switching signals on or off by receptor dimerization. Cell. 94:1998;277-280.
2. Blundell T.L., Cutfield J.F., Cutfield S.M., et al. Atomic positions in 2-zinc insulin crystals. Nature. 231:1971;506-511.
3. Blundell T.L., Dodson G.G., Mercola D., Hodgkin D.C. The structure, chemistry and biological activity of insulin. Adv. Prot. Chem. 26:1972;279-402.
4. Martin-Martinez M., Blundell T.L., Burke D., et al. Genomics, protein superfamilies and drug discovery. Campbell M.M., Blagbrough I.S. Medicinal Chemistry into the Millennium, Vol. 264. 2001;266-282 Royal Society of Chemistry. Special Publication.
5. Ullrich A., Bell J.R., Chen E.Y., et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature. 313:1985;756-761.
6. Ebina Y., Ellis L., Jarnagin K., et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell. 40:1985;747-758.
7. Hubbard S.R. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16:1997;5572-5581.
8. Bajaj M., Waterfield M.D., Schlessinger J., Taylor W.R., Blundell T. On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors. Biochim. Biophys. Acta. 916:1987;220-226.
9. Marino-Buslje C., Martin-Martinez M., Mizuguchi K., Siddle K., Blundell T.L. The insulin receptor: from protein sequence to structure. Biochem. Soc. Trans. 27:1999;715-726.
10. Ward C.W. Members of the insulin receptor family contain three fibronectin type III domains. Growth Factors. 16:1999;315-322.
11. Garrett T.P., McKern N.M., Lou M., et al. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature. 394:1998;395-399.
12. Schumacher R., Soos M.A., Schlessinger J., Brandenburg D., Siddle K., Ullrich A. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants. J. Biol. Chem. 268:1993;1087-1094.
13. Mynarcik D.C., Williams P.F., Schaffer L., Yu G.Q., Whittaker J. Identification of common ligand binding determinants of the insulin and insulin-like growth factor 1 receptors. Insights into mechanisms of ligand binding. J. Biol. Chem. 272:1997;18650-18655.
14. Whittaker J., Groth A.V., Mynarcik D.C., Pluzek L., Gadsbøll V.L., Whittaker L.J. Alanine scanning mutagenesis of a type I insulin-like growth factor receptor ligand binding site. J. Biol. Chem. 276:2001;43980-43986.
15. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Ann. Rev. Neurosci. 24:2001;1217-1281.
16. Angeletti R.H., Bradshaw R.A. Nerve growth factor from mouse submaxillary gland: amino acid sequence. Proc. Natl. Acad. Sci. 68:1971;2417-2420.
17. McDonald N.Q., Lapatto R., Murray-Rust J., Gunning J., Wlodawer A., Blundell T.L. New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. Nature. 354:1991;411-414.
18. Bax B., Blundell T.L., Murray-Rust J., McDonald N.Q. Structure of mouse 7S NGF: a complex of nerve growth factor with four binding proteins. Structure. 5:1997;1275-1285.
19. Wiesmann C., Ultsch M.H., Bass S.H., de Vos A.M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature. 401:1999;184-188.
20. Wiesmann C., de Vos A.M. Nerve growth factor: structure and function. Cell. Mol. Life Sci. 58:2001;748-759.
21. Gherardi E., Gray J., Stoker M., Perryman M., Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc. Natl. Acad. Sci. USA. 86:1989;5844-5848.
22. Miyazawa K., Tsubouchi H., Naka D., et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 163:1989;967-973.
23. Nakamura T., Nishizawa T., Hagiya M., et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 342:1989;440-443.
24. Chirgadze D.Y., Hepple J.P., Zhou H., Byrd R.A., Blundell T.L., Gherardi E. Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding. Nat. Struct. Biol. 6:1999;72-79.
25. Lietha D., Chirgadze D.Y., Mulloy B., Blundell T.L., Gherardi E. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. EMBO J. 20:2001;5543-5555.
26. Powers C.J., McLeskey S.W., Wellstein A. Fibroblast growth factors, their receptors and signaling. Endo. Rel. Cancer. 7:2000;165-197.
27. Ornitz D.M., Itoh N. Fibroblast growth factors, reviews. Genome Biol. 2:2001;3005.1-3005.12.
28. Sudhalter J., Folkman J., Svahn C.M., Bergendal K., D'Amore P.A. Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin. J. Biol. Chem. 264:1989;6892-6897.
29. Ornitz D.M., Yayon A., Flanagan J.G., Svahn C.M., Levi E., Peder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell Biol. 12:1992;240-247.
30. Faham S., Hileman R.E., Fromm J.R., Linhardt R.J., Rees D.C. Heparin structure and interactions with basic fibroblast growth factor. Science. 271:1996;1116-1120.
31. Di Gabriele A.D., Lax I., Chen D.I., et al. Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature. 393:1998;812-817.
32. Plotnikov A.N., Schlessinger J., Hubbard S.R., Mohammadi M. Structural basis for FGF receptor dimerization and activation. Cell. 98:1999;641-650.
33. Stauber D.J., DiGabriele A.D., Hendrickson W.A. Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl Acad. Sci. USA. 97:2000;49-54.
34. Schlessinger J., Plotnikov A.N., Ibrahimi O.A., et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell. 6:2000;743-750.
35. Pellegrini L., Burke D.F., von Delft F., Mulloy B., Blundell T.L. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature. 407:2000;1029-1034.
36. Ye S., Luo Y., Lu W., et al. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry. 40:2001;14429-14439.
37. Kreuger J., Salmivirta M., Sturiale L., Gimenez-Gallego G., Lindahl U. Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J. Biol. Chem. 276:2001;30744-30752.
38. Pellegrini L. Role of heparan sulfate in fibroblast growth factor signalling: a structural view. Curr. Opin. Struct. Biol. 11:2001;629-634.
39. Blundell T.L., Burke D.F., Chirgadze D., et al. Protein-protein interactions in receptor activation and intracellular signalling. Biol. Chem. 381:2000;955-959.